• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

头孢西丁和头孢噻吩对7312株临床分离菌的体外活性比较。

A comparison of the in vitro activity of cefoxitin and cephalothin against 7,312 clinical isolates.

作者信息

Lingaas E, Midtvedt T, Melby K, Dahl O U

出版信息

Chemotherapy. 1981;27(4):239-46. doi: 10.1159/000237986.

DOI:10.1159/000237986
PMID:7249786
Abstract

The antibacterial activity of cefoxitin and cephalothin was tested against 7,312 clinical isolates of aerobic pathogens. Cefoxitin was found to have a broad spectrum of activity. Among the gram-positive cocci, 99.1% of Staphylococcus aureus, 94.4% of Staphylococcus epidermidis and 98.1% of streptococci group B had a minimal inhibitory concentration of 16 microgram/ml or less, while only 4.6% of enterococci were sensitive to this concentration of cefoxitin. Among the gram-negative rods 94.4% of Escherichia coli, 89.3% of Klebsiella spp., 97.3% of Proteus mirabilis, 97.4% of Proteus vulgaris and 79.3% of Proteus morganii were sensitive to 16 microgram/ml of cefoxitin or less. The effect of Pseudomonas spp. and Acinetobacter calcoaceticus was negligible. Cefoxitin was less active than cephalothin against gram-positive cocci, the difference being most pronounced against enterococci. Cephalothin was also found to be more active than cefoxitin against P. mirabilis, while cefoxitin was superior to cephalothin against E. coli, Klebsiella spp., Enterobacter spp., P. vulgaris and P. morganii.

摘要

对7312株需氧病原菌临床分离株测试了头孢西丁和头孢噻吩的抗菌活性。发现头孢西丁具有广谱活性。在革兰氏阳性球菌中,99.1%的金黄色葡萄球菌、94.4%的表皮葡萄球菌和98.1%的B组链球菌的最低抑菌浓度为16微克/毫升或更低,而只有4.6%的肠球菌对该浓度的头孢西丁敏感。在革兰氏阴性杆菌中,94.4%的大肠杆菌、89.3%的克雷伯菌属、97.3%的奇异变形杆菌、97.4%的普通变形杆菌和79.3%的摩根氏变形杆菌对16微克/毫升或更低浓度的头孢西丁敏感。铜绿假单胞菌和醋酸钙不动杆菌的作用可忽略不计。头孢西丁对革兰氏阳性球菌的活性低于头孢噻吩,这种差异在肠球菌中最为明显。还发现头孢噻吩对奇异变形杆菌的活性高于头孢西丁,而头孢西丁对大肠杆菌、克雷伯菌属、肠杆菌属、普通变形杆菌和摩根氏变形杆菌的活性优于头孢噻吩。

相似文献

1
A comparison of the in vitro activity of cefoxitin and cephalothin against 7,312 clinical isolates.头孢西丁和头孢噻吩对7312株临床分离菌的体外活性比较。
Chemotherapy. 1981;27(4):239-46. doi: 10.1159/000237986.
2
Susceptibility of clinical isolates of bacteria to cefoxitin and cephalothin.临床分离细菌对头孢西丁和头孢噻吩的敏感性。
Antimicrob Agents Chemother. 1974 Sep;6(3):320-3. doi: 10.1128/AAC.6.3.320.
3
A comparison of the in vitro activity of a new cephalosporin, cefuroxime, and cephalothin against 810 clinical isolates.一种新型头孢菌素头孢呋辛与头孢噻吩对810株临床分离菌的体外活性比较。
NIPH Ann. 1979 Dec;2(2):31-40.
4
Susceptibility of clinical strains of bacteria to cefoxitin.临床细菌菌株对头孢西丁的敏感性
N Z Med J. 1981 Sep 9;94(691):173-4.
5
In vitro studies of cefamandole.头孢孟多的体外研究。
Antimicrob Agents Chemother. 1976 Mar;9(3):452-7. doi: 10.1128/AAC.9.3.452.
6
[In vitro activity of cefoxitin, a new cephalosporin (author's transl)].新型头孢菌素头孢西丁的体外活性(作者译)
MMW Munch Med Wochenschr. 1976 Nov 5;118(45):1469-72.
7
Cefoxitin, a new semi-synthetic cephamycin: an in-vitro and in-vivo comparison with cephalothin.头孢西丁,一种新型半合成头孢霉素:与头孢噻吩的体外及体内比较
Br Med J. 1973 Dec 15;4(5893):653-5. doi: 10.1136/bmj.4.5893.653.
8
[Antibacterial activity of cefotaxim in comparison with seven cephalosporins].头孢噻肟与七种头孢菌素的抗菌活性比较
Infection. 1979;7(5):231-6. doi: 10.1007/BF01648932.
9
[Microbiological evaluation of cefoxitin, a new beta-lactamase resistant cephamycin antibiotic, compared to cephalothin, cephaloridine and cefazolin].[新型耐β-内酰胺酶头孢霉素抗生素头孢西丁与头孢噻吩、头孢噻啶和头孢唑林的微生物学评价]
Fortschr Med. 1978 Aug 10;96(30):1510-7.
10
Cefoxitin and cephalothin: antimicrobial activity, human pharmacokinetics, and toxicology.头孢西丁和头孢噻吩:抗菌活性、人体药代动力学及毒理学
Antimicrob Agents Chemother. 1974 Sep;6(3):290-9. doi: 10.1128/AAC.6.3.290.